The Enterprise Value as of December 2025 (TTM) for Medigen Vaccine Biologics Corporation (6547.TWO) is 12.63B

According to Medigen Vaccine Biologics Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 12.63B. This represents a change of -8.61% compared to the average of 13.82B of the last 4 quarters.

Medigen Vaccine Biologics Corporation (6547.TWO) Historical Enterprise Value (quarterly & annually)

How has 6547.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of Medigen Vaccine Biologics Corporation over the last ten years is 15.79B. The current 12.63B Enterprise Value has changed 7.90% with respect to the historical average. Over the past ten years (40 quarters), 6547.TWO's Enterprise Value was at its highest in in the December 2021 quarter at 62.10B. The Enterprise Value was at its lowest in in the September 2016 quarter at 0.

Medigen Vaccine Biologics Corporation (6547.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Medigen Vaccine Biologics Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Medigen Vaccine Biologics Corporation (6547.TWO) Average Enterprise Value

How has 6547.TWO Enterprise Value performed in the past?

The current Enterprise Value of Medigen Vaccine Biologics Corporation (6547.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Medigen Vaccine Biologics Corporation (6547.TWO) Enterprise Value vs. Peers

How is 6547.TWO’s Enterprise Value compared to its peers?

Medigen Vaccine Biologics Corporation’s Enterprise Value is greater than AP Biosciences Inc (12.07B), greater than PharmaEngine, Inc. (7.76B), greater than Adimmune Corporation (9.62B), greater than Acepodia, Inc. (4.40B), less than Tanvex BioPharma, Inc. (16.20B), greater than Foresee Pharmaceuticals Co., Ltd. (12.08B), less than Ever Supreme Bio Technology Co., Ltd (14.28B), greater than TaiDoc Technology Corporation (10.53B), greater than TaiDoc Technology Corporation (10.53B), greater than CHO Pharma, Inc. (6.08B),

Build a custom stock screener for Medigen Vaccine Biologics Corporation (6547.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Medigen Vaccine Biologics Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Medigen Vaccine Biologics Corporation (6547.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Medigen Vaccine Biologics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.